Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
The U.S. has administered more than 4.2 million coronavirus vaccine doses but is lagging behind several other countries as hospitalizations continue to surge following the holidays. The federal government had repeatedly promised 20 million people would have received their first shots by the end of the year; they didn't come close.
Dean Fanelli, Ph.D., a vaccine expert and an expert on pharmaceutical- and chemical-related technologies, joins us on the Big Time Talker podcast to discuss the vaccine roll-out, why the process is going slower than anticipated, and when all Americans can expect to receive their doses.
Dean is a partner in the Intellectual Property Department of Seyfarth Shaw LLP's Washington D.C. office, with over 20 years of experience in pharmaceutical and biotechnology IP management including in technology licensing/transactions, due diligence, prosecution and litigation.
Dr. Fanelli's focus is on pharmaceutical and chemical-related technologies including those in the fields of new chemical entities, pharmaceutical formulations, polymers, diagnostics, biologics, and medical devices. Dr. Fanelli graduated from The George Washington University Law School and received his Ph.D. in Organic Chemistry from Temple University, after receiving his B.S. in Chemistry from Villanova University.
The Big Time Talker podcast is a service of SpeakerMatch.com; subscribe today, or ask Alexa to play the Big Time Talker with Burke Allen.